[HTML][HTML] Retinitis pigmentosa: novel therapeutic targets and drug development

KY Wu, M Kulbay, D Toameh, AQ Xu, A Kalevar… - Pharmaceutics, 2023 - mdpi.com
Retinitis pigmentosa (RP) is a heterogeneous group of hereditary diseases characterized by
progressive degeneration of retinal photoreceptors leading to progressive visual decline. It …

Effects of medications on hypoxia‐inducible factor in the retina: A review

AH Kim, M Kolesnikova, WK Ngo… - Clinical & experimental …, 2023 - Wiley Online Library
Hypoxia‐inducible factor (HIF) plays a critical role in the mechanisms that allow cells to
adapt to various oxygen levels in the environment. Specifically, HIF‐1⍺ has shown to be …

[HTML][HTML] Metformin inhibits methylglyoxal-induced retinal pigment epithelial cell death and retinopathy via AMPK-dependent mechanisms: reversing mitochondrial …

P Sekar, G Hsiao, SH Hsu, DY Huang, WW Lin… - Redox Biology, 2023 - Elsevier
Diabetic retinopathy (DR) is a major cause of blindness in adult, and the accumulation of
advanced glycation end products (AGEs) is a major pathologic event in DR. Methylglyoxal …

HSP27 induced glaucomatous damage in mice of young and advanced age

C Erb, S Reinehr, C Theiss, HB Dick… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction Age-related diseases such as glaucoma, a leading cause of blindness, are
having an upward trend due to an aging society. In glaucoma, some patients display altered …

The Antidiabetic Drug Metformin Attenuated Depressive and Anxiety-like Behaviors and Oxidative Stress in the Brain in a Rodent Model of Inflammation Induced by …

FSH Kakhki, A Asghari, Z Bardaghi… - … Metabolic & Immune …, 2024 - benthamdirect.com
Background: Inflammation is considered to be a link between diabetes and central nervous
system (CNS) disorders, including depression and anxiety. Metformin is suggested to have …

Therapeutic Effects of Metformin on Central Nervous System Diseases: A Focus on Protection of Neurovascular Unit

C Cai, C Gu, C Meng, S He, L Thashi, D Deji… - Pharmaceutical …, 2024 - Springer
Metformin is one of the most commonly used oral hypoglycemic drugs in clinical practice,
with unique roles in neurodegeneration and vascular lesions. Neurodegeneration and …